Thomas Bo Jensen (Thomas B Jensen)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Venues

Clinical pharmacokinetics

Basic & clinical pharmacology & toxicology

Archives of disease in childhood. Fetal and neonatal edition

Scientific reports

Novo Nordisk A/S

University of Copenhagen (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Novo Nordisk A/S May 01 2020

Denmark

Resident in Clinical Pharmacology :: Medical & Science

Copenhagen University Hospital Bispebjerg Dec 01 2016 - Apr 30 2020

Denmark

MD, PhD student :: Department of Clinical Pharmacology

Brigham and Women's Hospital Sep 01 2018 - Feb 28 2019

United States

Visiting collaborator :: Division of Pharmacoepidemiology and Pharmacoeconomics

Education History

University of Copenhagen Dec 01 2016

Denmark

PHD

University of Copenhagen

Denmark

MSC

University of Copenhagen

Denmark

BSC

Publications

Wei-Qing Wang, Stephen C Bain, Fang Bian, Rui Chen, Sanaz Gabery, Shan Huang, Thomas Bo Jensen, Bifen Luo, Guoyue Yuan, Yanqiu Wang, null null
Efficacy and safety of oral semaglutide monotherapy vs placebo in a predominantly Chinese population with type 2 diabetes (PIONEER 11): a double-blind, Phase IIIa, randomised trial. Diabetologia (2024)
Marloes van Hout, Pablo Forte, Thomas Bo Jensen, Cristina Boschini, Tine A Baekdal
Effect of Various Dosing Schedules on the Pharmacokinetics of Oral Semaglutide: A Randomised Trial in Healthy Subjects. Clinical pharmacokinetics (2023)
Marloes van Hout, Pablo Forte, Thomas Bo Jensen, Cristina Boschini, Tine A Baekdal
Effect of Various Dosing Schedules on the Pharmacokinetics of Oral Semaglutide: A Randomised Trial in Healthy Subjects. Clinical pharmacokinetics (2023)
Marloes van Hout, Pablo Forte, Thomas Bo Jensen, Cristina Boschini, Tine A Baekdal
Correction to: Effect of Various Dosing Schedules on the Pharmacokinetics of Oral Semaglutide: A Randomised Trial in Healthy Subjects. Clinical pharmacokinetics (2023)
Astrid Blicher Schelde, Janne Petersen, Thomas Bo Jensen, Kirill Gromov, Søren Overgaard, Jonas Bjerring Olesen, Espen Jimenez-Solem
Thromboembolic and bleeding complications following primary total knee arthroplasty : a Danish nationwide cohort study. The bone & joint journal (10) (2021)
Thomas Bo Jensen, Jon Trærup Andersen, Espen Jimenez-Solem, Marie Lund
How patients in Denmark acquire their medicines: overview, data sources and implications for pharmacoepidemiology. Basic & clinical pharmacology & toxicology 128 (1) (2020)
Astrid Blicher Schelde, Janne Petersen, Thomas Bo Jensen, Kirill Gromov, Søren Overgaard, Jonas Bjerring Olesen, Espen Jimenez-Solem
Validation of registration of pharmacological treatment in the Danish Hip and Knee Arthroplasty Registers. Basic & clinical pharmacology & toxicology 128 (3) (2020)
Ditte Resendal Gotfredsen, Siri Vinther, Tonny Studsgaard Petersen, Rikke Cortes, Thomas Bo Jensen, Espen Jimenez-Solem, Mikkel Bring Christensen
Glycemic control and use of glucose-lowering medications in hospital-admitted type 2 diabetes patients over 80 years. Scientific reports 10 (1) (2020)
Thomas Bo Jensen, Jens Peter Kampmann, Jon Trærup Andersen
Patent ductus arteriosus closure: why same-dose oral ibuprofen is superior to intravenous. Archives of disease in childhood. Fetal and neonatal edition 105 (3) (2019)
Thomas Bo Jensen, Dorthe Bartels, Eva Aggerholm Sædder, Birgitte Klindt Poulsen, Stig Ejdrup Andersen, Mette Marie H Christensen, Lars Nielsen, Hanne Rolighed Christensen
The Danish model for the quick and safe implementation of infliximab and etanercept biosimilars. European journal of clinical pharmacology 76 (1) (2019)
Kasper M Petersen, Niklas R Jørgensen, Søren Bøgevig, Tonny S Petersen, Thomas Bo Jensen, Kim P Dalhoff, Mikkel B Christensen
Effects of high-dose, intravenous lipid emulsion on laboratory tests in humans: a randomized, placebo-controlled, double-blind, clinical crossover trial. Clinical chemistry and laboratory medicine 56 (12) (2019)
Thomas Bo Jensen, Espen Jimenez-Solem, Rikke Cortes, Cecilie Betzer, Sara Bøge Breinholt, Kasper Meidahl Petersen, Tonny Studsgaard Petersen, Jakob Kjellberg, Hanne Rolighed Christensen, Jon Trærup Andersen
Content and validation of the Electronic Patient Medication module (EPM)-the administrative in-hospital drug use database in the Capital Region of Denmark. Scandinavian journal of public health 48 (1) (2018)

Thomas Bo Jensen.css-eqlu8i{font-size:small;padding-left:4px;} (Thomas B Jensen)

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Bo Jensen (Thomas B Jensen)